InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Rodriguez Raul R, Chairman & CEO. Director active across 1 company, notably RIGEL PHARMACEUTICALS INC. Aggregated, 11 disclosures have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €772k. History available since 24 January 2022. The latest transaction was filed on 17 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Rodriguez Raul R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
53,915 shares0Common StockSEC:0000905148-26-000955:0
7,607 shares@ US$34.627.8% of flowCommon StockSEC:0000905148-26-000675:0
40,000 shares@ US$27.4032.5% of flowCommon StockSEC:0000905148-26-000495:0
4,952 shares@ US$20.9215.9% of flowCommon StockSEC:0000905148-25-000411:0
42,300 shares0Common StockSEC:0000905148-25-000301:0
45,000 shares@ US$21.4054.5% of flowCommon StockSEC:0000905148-25-000237:0
22,349 shares@ US$1.13031.4% of flowCommon StockSEC:0000905148-24-000445:0
400,000 shares0Common StockSEC:0000905148-24-000308:0
300,000 shares0Common StockSEC:0001140361-23-005036:0
1,000,000 shares@ US$0.68840.12% mcap100.0% of flowCommon StockSEC:0001567619-22-012778:0
Canonical exit: 7 Sept 2022 (T+90)
200,000 shares0Common StockSEC:0001567619-22-001779:0
11 of 11 declarations
About Rodriguez Raul R
RODRIGUEZ RAUL R is the CEO and President of RIGEL PHARMACEUTICALS INC. He leads the company and oversees its operations, ensuring it meets its strategic objectives. His experience in the pharmaceutical sector is essential in guiding the organization towards sustainable growth and continuous innovation.
